Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Clin Cancer Res. 2011 Jun 8;17(15):4996–5004. doi: 10.1158/1078-0432.CCR-10-3406

Table 2.

Clinicopathologic characteristics of 19 patients evaluated for phosphorylated p70S6K

Gender, No. (%)
 Male 15 (79)
 Female 4 (21)
Age, years
 Median (range) 64 (42–84)
Stage
 Locally advanced 5 (26)
 Recurrent or metastatic 14 (74)
Primary site, No. (%)
 Oral cavity 8 (42)
 Larynx 3 (16)
 Oropharynx 4 (21)
 Unknown primary 2 (11)
 Other 2 (11)
Prior treatment, No. (%)
 Surgery 15 (79)
 Radiotherapy 14 (74)
 Chemotherapy 14 (74)
 None 4 (21)
Cetuximab treatment
 Cetuximab alone 12 (63)
 Cetuximab concurrently with radiotherapy 7 (37)